Healio (4/17, Gramigna) reported a paper published in Brain, Behavior, and Immunity suggests that patients who recover from a coronavirus infection “may experience a significant neuropsychiatric burden long after the current pandemic.” The paper’s authors suggest, in the words of Healio, “researchers should conduct prospective neuropsychiatric and neuroimmune monitoring of those exposed to SARS-CoV-2 at various points in the life course to better understand the long-term impact of COVID-19, as well as to create a framework for the integration of psychoneuroimmunology into epidemiologic studies of pandemics.” The paper’s authors “wrote that influenza pandemics in the 18th and 19th centuries were followed by increased rates of insomnia, anxiety, depression, mania, suicidality and delirium,” while “outbreaks during the 21st century, such as SARS-CoV-1 in 2003, H1N1 in 2009 and MERS-CoV in 2012, were followed by increased rates of narcolepsy, seizures, encephalitis, Guillain-Barre syndrome and other neuromuscular and demyelinating conditions.”
Related Links:
— “COVID-19 survivors may face ‘significant neuropsychiatric burden,’ experts suggest, “Joe Gramigna, Healio, April 17, 2020